These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34085148)

  • 41. Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort.
    Shah A; Hoffman EM; Mauermann ML; Loprinzi CL; Windebank AJ; Klein CJ; Staff NP
    J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):636-641. PubMed ID: 29439162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.
    McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB;
    Support Care Cancer; 2017 Nov; 25(11):3485-3493. PubMed ID: 28589310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective Effects of Vitamin E on Chemotherapy-Induced Peripheral Neuropathy: A Meta-Analysis of Randomized Controlled Trials.
    Miao H; Li R; Chen D; Hu J; Chen Y; Xu C; Wen Z
    Ann Nutr Metab; 2021; 77(3):127-137. PubMed ID: 34148036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of peripheral neuropathy induced by chemotherapy in adults with cancer: a review.
    Al-Atiyyat N; Obaid A
    Int J Palliat Nurs; 2017 Jan; 23(1):13-17. PubMed ID: 28132604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy.
    Molassiotis A; Cheng HL; Lopez V; Au JSK; Chan A; Bandla A; Leung KT; Li YC; Wong KH; Suen LKP; Chan CW; Yorke J; Farrell C; Sundar R
    BMC Cancer; 2019 Feb; 19(1):132. PubMed ID: 30736741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer.
    Bulls HW; Hoogland AI; Kennedy B; James BW; Arboleda BL; Apte S; Chon HS; Small BJ; Gonzalez BD; Jim HSL
    Gynecol Oncol; 2019 Feb; 152(2):310-315. PubMed ID: 30558975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study.
    Tsurutani J; Sakata Y; Matsuoka T
    Breast Cancer; 2019 Mar; 26(2):235-243. PubMed ID: 30324551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.
    Pereira S; Fontes F; Sonin T; Dias T; Fragoso M; Castro-Lopes JM; Lunet N
    Support Care Cancer; 2016 Apr; 24(4):1571-81. PubMed ID: 26384827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
    Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
    [No Abstract]   [Full Text] [Related]  

  • 50. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
    Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
    Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lagged Relationships Among Chemotherapy-Induced Peripheral Neuropathy, Sleep Quality, and Physical Activity During and After Chemotherapy.
    Bulls HW; Hoogland AI; Small BJ; Kennedy B; James BW; Arboleda BL; Shahzad MMK; Gonzalez BD; Jim HSL
    Ann Behav Med; 2021 Aug; 55(9):844-852. PubMed ID: 33196081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer.
    Kanda K; Fujimoto K; Mochizuki R; Ishida K; Lee B
    BMC Cancer; 2019 Sep; 19(1):904. PubMed ID: 31506070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy.
    Hung HW; Liu CY; Chen HF; Chang CC; Chen SC
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34073174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy-Induced Peripheral Neuropathy Assessment Tools: A Systematic Review.
    Haryani H; Fetzer SJ; Wu CL; Hsu YY
    Oncol Nurs Forum; 2017 May; 44(3):E111-E123. PubMed ID: 28635977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models.
    Eldridge S; Guo L; Hamre J
    Toxicol Pathol; 2020 Jan; 48(1):190-201. PubMed ID: 31331249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations.
    Hou S; Huh B; Kim HK; Kim KH; Abdi S
    Pain Physician; 2018 Nov; 21(6):571-592. PubMed ID: 30508986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between diabetes mellitus and gastroesophageal reflux disease: A meta-analysis.
    Sun XM; Tan JC; Zhu Y; Lin L
    World J Gastroenterol; 2015 Mar; 21(10):3085-92. PubMed ID: 25780309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review.
    Mols F; Beijers T; Vreugdenhil G; van de Poll-Franse L
    Support Care Cancer; 2014 Aug; 22(8):2261-9. PubMed ID: 24789421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapy-Induced Neuropathy and Diabetes: A Scoping Review.
    Sempere-Bigorra M; Julián-Rochina I; Cauli O
    Curr Oncol; 2021 Aug; 28(4):3124-3138. PubMed ID: 34436039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.